AU2003246752A1 - Use of densin-like compounds - Google Patents

Use of densin-like compounds

Info

Publication number
AU2003246752A1
AU2003246752A1 AU2003246752A AU2003246752A AU2003246752A1 AU 2003246752 A1 AU2003246752 A1 AU 2003246752A1 AU 2003246752 A AU2003246752 A AU 2003246752A AU 2003246752 A AU2003246752 A AU 2003246752A AU 2003246752 A1 AU2003246752 A1 AU 2003246752A1
Authority
AU
Australia
Prior art keywords
densin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246752A
Inventor
Heikki Ahola
Harry Holthofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GLOMEGA Inc Oy
Original Assignee
GLOMEGA Inc Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GLOMEGA Inc Oy filed Critical GLOMEGA Inc Oy
Publication of AU2003246752A1 publication Critical patent/AU2003246752A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
AU2003246752A 2002-07-24 2003-07-23 Use of densin-like compounds Abandoned AU2003246752A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20021406 2002-07-24
FI20021406A FI20021406A0 (en) 2002-07-24 2002-07-24 Use of such compounds
PCT/FI2003/000579 WO2004009102A1 (en) 2002-07-24 2003-07-23 Use of densin-like compounds

Publications (1)

Publication Number Publication Date
AU2003246752A1 true AU2003246752A1 (en) 2004-02-09

Family

ID=8564376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246752A Abandoned AU2003246752A1 (en) 2002-07-24 2003-07-23 Use of densin-like compounds

Country Status (3)

Country Link
AU (1) AU2003246752A1 (en)
FI (1) FI20021406A0 (en)
WO (1) WO2004009102A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI991369A0 (en) * 1999-06-15 1999-06-15 Harry Holthoefer Expression of the pancreas and kidney collar Use of soluble protein molecules

Also Published As

Publication number Publication date
FI20021406A0 (en) 2002-07-24
WO2004009102A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003279366A1 (en) Novel compounds
AU2003294778A1 (en) Novel use of lycopene
AU2003236991A1 (en) Representations of processes
AU2003250858A1 (en) Use of organic compounds
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003215150A1 (en) Therapeutic compounds
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
EP1572950A3 (en) Single domain tdf-related compounds and analogs thereof
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003280578A1 (en) Heterocyclic compounds
AU2003246465A1 (en) Single-use lavatory
AU2002952559A0 (en) New use
AUPS044102A0 (en) New compound
AU2003262141A1 (en) Preperation of desloratatine
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003264443A1 (en) Preparation for external use
AU2003260509A1 (en) Acetylene compounds
AU2002951868A0 (en) Compound i

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase